Figure 1From: Comparative efficacy of AHU-377, a potent neprilysin inhibitor, in two rat models of volume-dependent hypertensionComparison of peak fall in MAP (relative to baseline; A) and 12 hour vehicle adjusted AUC MAP (B) following oral administration of AHU-377 (30 and100 mg/kg, PO) in conscious Dahl-SS and DOCA-salt hypertensive rats (n=4-7 per treatment group).Back to article page